Although the molecular mechanisms that determine how JAM-A modulates phagocytosis and IgA production in the setting of a polymicrobial infection remain to be determined, inhibiting JAM-A represents an unexpected strategy for the treatment of sepsis. This evidence concerns the gene CD79A and Sepsis.